A new concept for cancer therapy: out-competing the aggressor
2008

Out-competing Cancer Cells with Engineered Cells

publication Evidence: moderate

Author Information

Author(s): Thomas S Deisboeck, Zhihui Wang

Primary Institution: Harvard-MIT (HST) Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital

Hypothesis

Can engineered cells out-compete native cancer cells for resources in the tumor microenvironment?

Conclusion

The study suggests that engineered cells can effectively control tumor growth by out-competing native cancer cells for limited resources.

Supporting Evidence

  • The model shows that engineered cells can dominate the tumor population if they have a higher proliferation rate.
  • Simulations indicate that higher proliferation rates of engineered cells lead to faster control of tumor growth.
  • Results suggest that once engineered cells outnumber native tumor cells, they can effectively suppress tumor growth.

Takeaway

Scientists think that if they can make special cells that grow faster than cancer cells, those special cells can take away the food and space cancer cells need to grow.

Methodology

A three-dimensional agent-based model was developed to simulate the growth dynamics of engineered and native tumor cells.

Potential Biases

Potential risks include the engineered cells causing local tumor invasion or distant metastasis.

Limitations

The model oversimplifies the tumor microenvironment by only considering glucose as a nutrient.

Digital Object Identifier (DOI)

10.1186/1475-2867-8-19

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication